These are the words of Swiss chemist Albert Hofmann after accidentally going on the world's first acid trip. In 1938, Hofmann began investigating the chemical and pharmacological properties of ergot, a rye fungus.
We parked near school and he grabbed his book-bag as I moved over to the drivers seat, and I wished my son well with his audition. Anticipating my concern he replied, "Thanks... and I'll do some LSD after that." Like father, like son, it's been a long strange trip.
Psychedelic-assisted therapy has not only proven effective in alleviating terminally ill patients' anxiety, but has also yielded promising results in treating a variety of intractable psychological conditions over the years.
It's hard to mistake the Magic Bus for any other vehicle that departs from San Francisco's touristy Union Square. The psychedelic colors that wind around the former school bus make it perfectly clear that this is a ride back in time. To the 1960s, to be exact.
Fifty years after Tom Wolfe documented that epic LSD trip on a bus called "Further," a new breed of scientists is attempting once again to put Schedule I drugs into words (peer-reviewed ones, thankfully). The rigorous and careful exploration of these substances points to four key benefits.
We were in my cramped, dingy bedroom in the Mission District flat I shared with three other San Francisco State students in that spring of 1967. "What's that?" I asked of tablets in a baggie she held up to me. "Acid," Ruth replied.